Alerts will be sent to your verified email
Verify EmailSMSPHARMA
SMS Pharmaceuticals
|
Natco Pharma
|
Granules India
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.71 % | 8.0 % | 1.17 % |
Financials
|
|||
5 yr Average ROE
|
9.69 % | 12.01 % | 18.62 % |
5yr average Equity Multiplier
|
1.87 | 1.19 | 1.78 |
5yr Average Asset Turnover Ratio
|
0.67 | 0.44 | 0.84 |
5yr Avg Net Profit Margin
|
7.6 % | 22.3 % | 12.53 % |
Price to Book
|
3.67 | 3.49 | 3.47 |
P/E
|
45.39 | 14.46 | 26.02 |
5yr Avg Cash Conversion Cycle
|
120.64 Days | 55.67 Days | 49.48 Days |
Inventory Days
|
112.23 Days | 103.24 Days | 66.04 Days |
Days Receivable
|
65.01 Days | 93.53 Days | 75.78 Days |
Days Payable
|
67.72 Days | 180.2 Days | 105.66 Days |
5yr Average Interest Coverage Ratio
|
5.26 | 37.72 | 19.25 |
5yr Avg ROCE
|
13.13 % | 15.05 % | 21.19 % |
5yr Avg Operating Profit Margin
|
19.47 % | 34.37 % | 21.42 % |
5 yr average Debt to Equity
|
0.52 | 0.07 | 0.46 |
5yr CAGR Net Profit
|
n/a | 2.11 % | 16.92 % |
5yr Average Return on Assets
|
5.2 % | 10.04 % | 10.57 % |
Shareholdings
|
|||
Promoter Holding
|
64.67 % | 49.71 % | 41.96 % |
Share Pledged by Promoters
|
19.4 % | 0.0 | 4.03 % |
Change in Promoter Holding (3 Yrs)
|
-2.62 % | 0.84 % | -0.08 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.98 % | -5.37 % | 5.8 % |
SMS Pharmaceuticals
|
Natco Pharma
|
Granules India
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|